Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2018-2029)
2.2 Global Parkinson’s Disease Therapeutics Growth Trends by Region
2.2.1 Parkinson’s Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Parkinson’s Disease Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Parkinson’s Disease Therapeutics Market Dynamics
2.3.1 Parkinson’s Disease Therapeutics Industry Trends
2.3.2 Parkinson’s Disease Therapeutics Market Drivers
2.3.3 Parkinson’s Disease Therapeutics Market Challenges
2.3.4 Parkinson’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Parkinson’s Disease Therapeutics by Players
3.1.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2018-2024)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Parkinson’s Disease Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2022
3.5 Global Key Players of Parkinson’s Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Parkinson’s Disease Therapeutics, Product and Application
3.7 Global Key Players of Parkinson’s Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2024-2029)
5 Parkinson’s Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Parkinson’s Disease Therapeutics Market Size (2018-2029)
6.2 North America Parkinson’s Disease Therapeutics Market Size by Type
6.2.1 North America Parkinson’s Disease Therapeutics Market Size by Type (2018-2024)
6.2.2 North America Parkinson’s Disease Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
6.3 North America Parkinson’s Disease Therapeutics Market Size by Application
6.3.1 North America Parkinson’s Disease Therapeutics Market Size by Application (2018-2024)
6.3.2 North America Parkinson’s Disease Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
6.4 North America Parkinson’s Disease Therapeutics Market Size by Country
6.4.1 North America Parkinson’s Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
6.4.3 North America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Parkinson’s Disease Therapeutics Market Size (2018-2029)
7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson’s Disease Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson’s Disease Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe Parkinson’s Disease Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country
7.4.1 Europe Parkinson’s Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Parkinson’s Disease Therapeutics Market Size (2018-2029)
8.2 China Parkinson’s Disease Therapeutics Market Size by Type
8.2.1 China Parkinson’s Disease Therapeutics Market Size by Type (2018-2024)
8.2.2 China Parkinson’s Disease Therapeutics Market Size by Type (2024-2029)
8.2.3 China Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
8.3 China Parkinson’s Disease Therapeutics Market Size by Application
8.3.1 China Parkinson’s Disease Therapeutics Market Size by Application (2018-2024)
8.3.2 China Parkinson’s Disease Therapeutics Market Size by Application (2024-2029)
8.3.3 China Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Parkinson’s Disease Therapeutics Market Size (2018-2029)
9.2 Asia Parkinson’s Disease Therapeutics Market Size by Type
9.2.1 Asia Parkinson’s Disease Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia Parkinson’s Disease Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
9.3 Asia Parkinson’s Disease Therapeutics Market Size by Application
9.3.1 Asia Parkinson’s Disease Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia Parkinson’s Disease Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
9.4 Asia Parkinson’s Disease Therapeutics Market Size by Region
9.4.1 Asia Parkinson’s Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Parkinson’s Disease Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia Parkinson’s Disease Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction
11.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.1.5 Abbvie Recent Developments
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Parkinson’s Disease Therapeutics Introduction
11.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.2.5 Biogen Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 F. Hoffman-La Roche
11.4.1 F. Hoffman-La Roche Company Details
11.4.2 F. Hoffman-La Roche Business Overview
11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction
11.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.4.5 F. Hoffman-La Roche Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 H. Lundbeck A/S
11.6.1 H. Lundbeck A/S Company Details
11.6.2 H. Lundbeck A/S Business Overview
11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction
11.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.6.5 H. Lundbeck A/S Recent Developments
11.7 Impax Labs
11.7.1 Impax Labs Company Details
11.7.2 Impax Labs Business Overview
11.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction
11.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.7.5 Impax Labs Recent Developments
11.8 Newron Pharmaceuticals SpA
11.8.1 Newron Pharmaceuticals SpA Company Details
11.8.2 Newron Pharmaceuticals SpA Business Overview
11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction
11.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.8.5 Newron Pharmaceuticals SpA Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction
11.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.9.5 Novartis AG Recent Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction
11.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.10.5 Orion Corporation Recent Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.12 UCB S.A.
11.12.1 UCB S.A. Company Details
11.12.2 UCB S.A. Business Overview
11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction
11.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.12.5 UCB S.A. Recent Developments
11.13 Livzon Pharmaceutical
11.13.1 Livzon Pharmaceutical Company Details
11.13.2 Livzon Pharmaceutical Business Overview
11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.13.4 Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.13.5 Livzon Pharmaceutical Recent Developments
11.14 Haisco Pharmaceutical
11.14.1 Haisco Pharmaceutical Company Details
11.14.2 Haisco Pharmaceutical Business Overview
11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.14.4 Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.14.5 Haisco Pharmaceutical Recent Developments
11.15 Jingxin Pharmaceutical
11.15.1 Jingxin Pharmaceutical Company Details
11.15.2 Jingxin Pharmaceutical Business Overview
11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.15.4 Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.15.5 Jingxin Pharmaceutical Recent Developments
11.16 Dongcheng Biochemicals
11.16.1 Dongcheng Biochemicals Company Details
11.16.2 Dongcheng Biochemicals Business Overview
11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Introduction
11.16.4 Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.16.5 Dongcheng Biochemicals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Transdermal
Table 4. Key Players of Subcutaneous
Table 5. Key Players of Intestinal Infusion
Table 6. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Parkinson’s Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Parkinson’s Disease Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Parkinson’s Disease Therapeutics Market Share by Region (2018-2024)
Table 10. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Parkinson’s Disease Therapeutics Market Share by Region (2024-2029)
Table 12. Parkinson’s Disease Therapeutics Market Trends
Table 13. Parkinson’s Disease Therapeutics Market Drivers
Table 14. Parkinson’s Disease Therapeutics Market Challenges
Table 15. Parkinson’s Disease Therapeutics Market Restraints
Table 16. Global Parkinson’s Disease Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Parkinson’s Disease Therapeutics Revenue Share by Players (2018-2024)
Table 18. Global Top Parkinson’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 19. Global Parkinson’s Disease Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Parkinson’s Disease Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Parkinson’s Disease Therapeutics, Product and Application
Table 23. Global Key Players of Parkinson’s Disease Therapeutics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Parkinson’s Disease Therapeutics Revenue Share by Application (2018-2024)
Table 31. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Parkinson’s Disease Therapeutics Revenue Share by Application (2024-2029)
Table 33. North America Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Parkinson’s Disease Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Parkinson’s Disease Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Parkinson’s Disease Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Parkinson’s Disease Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Parkinson’s Disease Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Parkinson’s Disease Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Parkinson’s Disease Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Parkinson’s Disease Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Parkinson’s Disease Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Parkinson’s Disease Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Abbvie Company Details
Table 66. Abbvie Business Overview
Table 67. Abbvie Parkinson’s Disease Therapeutics Product
Table 68. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 69. Abbvie Recent Developments
Table 70. Biogen Company Details
Table 71. Biogen Business Overview
Table 72. Biogen Parkinson’s Disease Therapeutics Product
Table 73. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 74. Biogen Recent Developments
Table 75. Boehringer Ingelheim GmbH Company Details
Table 76. Boehringer Ingelheim GmbH Business Overview
Table 77. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product
Table 78. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 79. Boehringer Ingelheim GmbH Recent Developments
Table 80. F. Hoffman-La Roche Company Details
Table 81. F. Hoffman-La Roche Business Overview
Table 82. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product
Table 83. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 84. F. Hoffman-La Roche Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Parkinson’s Disease Therapeutics Product
Table 88. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. H. Lundbeck A/S Company Details
Table 91. H. Lundbeck A/S Business Overview
Table 92. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product
Table 93. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 94. H. Lundbeck A/S Recent Developments
Table 95. Impax Labs Company Details
Table 96. Impax Labs Business Overview
Table 97. Impax Labs Parkinson’s Disease Therapeutics Product
Table 98. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 99. Impax Labs Recent Developments
Table 100. Newron Pharmaceuticals SpA Company Details
Table 101. Newron Pharmaceuticals SpA Business Overview
Table 102. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product
Table 103. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 104. Newron Pharmaceuticals SpA Recent Developments
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Parkinson’s Disease Therapeutics Product
Table 108. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 109. Novartis AG Recent Developments
Table 110. Orion Corporation Company Details
Table 111. Orion Corporation Business Overview
Table 112. Orion Corporation Parkinson’s Disease Therapeutics Product
Table 113. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 114. Orion Corporation Recent Developments
Table 115. Teva Pharmaceutical Industries Ltd. Company Details
Table 116. Teva Pharmaceutical Industries Ltd. Business Overview
Table 117. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product
Table 118. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 119. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 120. UCB S.A. Company Details
Table 121. UCB S.A. Business Overview
Table 122. UCB S.A. Parkinson’s Disease Therapeutics Product
Table 123. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 124. UCB S.A. Recent Developments
Table 125. Livzon Pharmaceutical Company Details
Table 126. Livzon Pharmaceutical Business Overview
Table 127. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 128. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 129. Livzon Pharmaceutical Recent Developments
Table 130. Haisco Pharmaceutical Company Details
Table 131. Haisco Pharmaceutical Business Overview
Table 132. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 133. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 134. Haisco Pharmaceutical Recent Developments
Table 135. Jingxin Pharmaceutical Company Details
Table 136. Jingxin Pharmaceutical Business Overview
Table 137. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 138. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 139. Jingxin Pharmaceutical Recent Developments
Table 140. Dongcheng Biochemicals Company Details
Table 141. Dongcheng Biochemicals Business Overview
Table 142. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product
Table 143. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 144. Dongcheng Biochemicals Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Parkinson’s Disease Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Transdermal Features
Figure 5. Subcutaneous Features
Figure 6. Intestinal Infusion Features
Figure 7. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Parkinson’s Disease Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Parkinson’s Disease Therapeutics Report Years Considered
Figure 13. Global Parkinson’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Parkinson’s Disease Therapeutics Market Share by Region: 2022 VS 2029
Figure 16. Global Parkinson’s Disease Therapeutics Market Share by Players in 2022
Figure 17. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Therapeutics Revenue in 2022
Figure 19. North America Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
Figure 21. North America Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
Figure 22. North America Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 23. United States Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Parkinson’s Disease Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
Figure 27. Europe Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
Figure 28. Europe Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Parkinson’s Disease Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
Figure 37. China Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
Figure 38. Asia Parkinson’s Disease Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
Figure 40. Asia Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
Figure 41. Asia Parkinson’s Disease Therapeutics Market Share by Region (2018-2029)
Figure 42. Japan Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 52. Brazil Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 59. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 61. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 63. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 64. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 65. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 66. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 67. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 68. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 69. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 70. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 71. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 72. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 73. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed